quinazolines has been researched along with Angina Pectoris, Variant in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, TY; Lin, GM; Wang, WB | 1 |
| Filipchuk, N; Hillis, LD; Winniford, MD | 1 |
| Atlas, D; Benhorin, J; Gottlieb, S; Keren, A; Stern, S; Tzivoni, D | 1 |
1 trial(s) available for quinazolines and Angina Pectoris, Variant
| Article | Year |
|---|---|
Alpha-adrenergic blockade for variant angina: a long-term, double-blind, randomized trial.
Topics: Adrenergic alpha-Antagonists; Adult; Angina Pectoris, Variant; Blood Pressure; Clinical Trials as Topic; Coronary Vasospasm; Double-Blind Method; Heart Rate; Humans; Male; Middle Aged; Prazosin; Quinazolines; Random Allocation | 1983 |
2 other study(ies) available for quinazolines and Angina Pectoris, Variant
| Article | Year |
|---|---|
Acute coronary syndromes and Anagrelide.
Topics: Angina Pectoris, Variant; Female; Humans; Middle Aged; Platelet Aggregation Inhibitors; Quinazolines; Thrombocythemia, Essential; Treatment Outcome | 2007 |
Prazosin therapy for refractory variant angina.
Topics: Aged; Angina Pectoris, Variant; Coronary Vasospasm; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Prazosin; Quinazolines | 1983 |